IMPACT-CABG Trial: Implantation of CD133(+) Stem Cells in Patients Undergoing Coronary Bypass Surgery—Presentation of the First Treated Patient

The IMPACT-CABG study is the first Canadian randomized-controlled phase II clinical trial aiming to assess the effect of intramyocardial (IM) injections of CD133(+)-selected stem cells in patients referred for coronary artery bypass graft (CABG) with a “chronic” myocardial infarction and persistent...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Forcillo, Jessica, Stevens, Louis-Mathieu, Mansour, Samer, Prieto, Ignacio, Roy, Denis-Claude, Noiseux, Nicolas
Natura: Artigo
Lingua:Inglês
Pubblicazione: Hindawi Publishing Corporation 2011
Soggetti:
Case Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3505958/
https://ncbi.nlm.nih.gov/pubmed/23213603
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2011/685394
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi